Protagonist Therapeutics Inc
PTGX·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$144.48
Today
+0.5%
YTD
+65.8%
About
Protagonist Therapeutics is a healthcare company based in Newark, California, US and established in 1996. Operating locally, the company aims to meet as-yet-unmet medical requirements through the use of peptide drugs. It is traded on the NASDAQ GM under the stock ticker PTGX. PTGX stock is available on eToro. Learn more now!
Price chart
Closing price history for PTGX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)135.60
P/S (TTM)35.41
P/B (TTM)10.81
Market cap$9.10B
Cap tierMid-cap
Industry avg P/E-7.40
Profitability
Gross margin99.45%
EBIT margin20.69%
Net margin76.28%
ROE10.98%
ROA10.34%
Earnings & Revenue
Revenue (TTM)$281.99M
Revenue growth (1Y)+34.8%
EPS (TTM)$1.04
Free cash flow$130.58M
Total debt$9.22M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.57
Employees132
Next earnings5 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.